Suchergebnisse - "Kazandjian, Dickran"

PubPharm (19)

1

Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma

enthalten in: Nature communications | 2023

von Coffey, D. | Maura, F. | Gonzalez-Kozlova, E. | +20

2

MRD and Plasma Cell Dynamics after CAR T-cell Therapy in Myeloma

enthalten in: Blood cancer discovery | 2023

von Landgren, O. | Kazandjian, D.

CommentOn: Blood Cancer Discov. 2023 Sep 1;4(5):365-373. - PMID 37486974

3

Extreme body mass index and survival in newly diagnosed multiple myeloma patients

enthalten in: Blood cancer journal | 2023

von Shah, U. | Whiting, K. | Devlin, S. | +16

4

Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma : pooled analysis of four single-arm studies

enthalten in: Leukemia & lymphoma | 2022

von Landgren, O. | Kazandjian, D. | Roussel, M. | +7

5

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma

enthalten in: Nature communications | 2022

von Yang, Y. | Bolomsky, A. | Oellerich, T. | +23

ErratumIn: Nat Commun. 2022 Oct 3;13(1):5830. - PMID 36192480

6

Modern Myeloma Therapy + Sustained Minimal Residual Disease-Negative = (Functional) Cure!

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Landgren, O. | Kazandjian, D.

CommentOn: J Clin Oncol. 2022 Sep 1;40(25):2889-2900. - PMID 35377708

7

Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies

enthalten in: JCO global oncology | 2022

von Fatoki, R. | Koehn, K. | Kelkar, A. | +8

8

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma : A Phase 2 Nonrandomized Controlled Trial

enthalten in: JAMA oncology | 2021

von Kazandjian, D. | Hill, E. | Dew, A. | +31

9

A new era of novel immunotherapies for multiple myeloma

enthalten in: Lancet (London, England) | 2021

von Kazandjian, D. | Landgren, O.

10

The mutagenic impact of melphalan in multiple myeloma

enthalten in: Leukemia | 2021

von Maura, F. | Weinhold, N. | Diamond, B. | +4